Anterior Mediastinum Teratoma: A Case Report

• Sponsor: Faculdade de Medicina de Catanduva (Other)
• Overall Status: Completed
• CT.gov ID: NCT00836121
• Collaborator: (none)
• Enrollment: 1
• Location: 1
• Duration (Months): 3
• Patients Per Site Per Month: 0.3

Study Details

Study Description

Brief Summary

The investigators report a case of a 39-year-old man who presented an anterior mediastinal cystic mature teratoma. Those kind of tumor contain elements derived from more than one of the three primary germ layers (ectoderm, mesoderm, endoderm), frequently arranged in a haphazard manner. They arise from totipotent cells and, therefore, are primarily found in gonads, and more rarely in primitive cells kidnapped in other parts of the body. The tissues are immature to well differentiated and foreign to the anatomic site. Mature teratomas are either cystic or solid, although the cystic presentation predominates in gonadal sites. Benign teratomas are the most common mediastinal germ cell tumor, accounting 70% of the mediastinal germ cell tumors in children and 60% of those in adults. Immature teratomas are potentially malignant tumors; their prognosis is influenced by the anatomic site of the tumor, patient age, and the fraction of the tumor that is immature. Treatment of benign mediastinal teratoma includes complete surgical resection, with results in a excellent long-term cure rates. Complete resection of teratomas should be the goal of treatment.

Condition or Disease	Intervention/Treatment	Phase
Teratoma	Procedure: right thoracotomy

Study Design

• Study Type: Observational
• Actual Enrollment: 1 participants
• Observational Model: Case-Only
• Official Title: Case Report of a 39 Years Old Man That Has Been Cured by a Total Resection of a Anterior Mediastinum Teratoma.
• Study Start Date: Sep 1, 2008
• Actual Primary Completion Date: Nov 1, 2008
• Actual Study Completion Date: Dec 1, 2008

Arms and Interventions

Arm	Intervention/Treatment
tumor	Procedure: right thoracotomy; complete surgical resection

Outcome Measures

Primary Outcome Measures

1. cure [one month after surgery]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 39 Years to 39 Years
• Sexes Eligible for Study: Male
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Clinical diagnosis of mediastinum teratoma

Exclusion Criteria:

• Tumor absent

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Faculdade de medicina de Catanduva	Catanduva	São Paulo	Brazil	15809-145

Sponsors and Collaborators

• Faculdade de Medicina de Catanduva

Investigators

• Principal Investigator: Stella MF Giolo, student, Faculdade de Medicina de Catanduva

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00836121
• Other Study ID Numbers: FAMECA2009; SMFG2009
• First Posted: Feb 4, 2009
• Last Update Posted: Feb 4, 2009
• Last Verified: Feb 1, 2009

• Keywords provided by , ,: Teratoma; Mediastinum
• Additional relevant MeSH terms: Teratoma

Study Results

No Results Posted as of Feb 4, 2009